BioDelivery Sciences International, Inc.
BDSI
BDSI was delisted on the 22nd of March, 2022.
75 hedge funds and large institutions have $137M invested in BioDelivery Sciences International, Inc. in 2013 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 27 increasing their positions, 20 reducing their positions, and 10 closing their positions.
105% more call options, than puts
Call options by funds: $1.07M | Put options by funds: $521K
70% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 10
35% more repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 20
10% more funds holding
Funds holding: 68 → 75 (+7)
2% more capital invested
Capital invested by funds: $133M → $137M (+$3.12M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VAM
Visium Asset Management
New York
|
+$3.09M |
| 2 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
+$3M |
| 3 |
TM
Tiger Management
New York
|
+$2.63M |
| 4 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$2.61M |
| 5 |
Millennium Management
New York
|
+$1.71M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$14.2M |
| 2 |
DM
Deerfield Management
New York
|
-$4.42M |
| 3 |
SC
Sophrosyne Capital
New York
|
-$4.02M |
| 4 |
CM
Castleark Management
Chicago,
Illinois
|
-$2.87M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$815K |
BDSI Hedge Fund Activity: Q4 2013 in Review
75 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in BioDelivery Sciences International, Inc. (BDSI) for Q4 2013, worth a combined $137M — up 2.3% from $133M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new BDSI positions and 10 closed out — a net gain of 7 holders — while 27 added to existing stakes and 20 trimmed.
The largest buyer was Visium Asset Management, adding an estimated $3.09M. The largest seller was Fidelity Investments, cutting an estimated $14.2M.
- 75 institutional investors held BioDelivery Sciences International, Inc. (BDSI) as of Q4 2013, up from 68 in Q3 2013.
- Funds reported $137M of BioDelivery Sciences International, Inc. stock for Q4 2013, up 2.3% quarter-over-quarter.
- 17 funds opened new BioDelivery Sciences International, Inc. positions in Q4 2013 and 10 closed out, a net change of +7 holders.
- The largest BioDelivery Sciences International, Inc. buyer in Q4 2013 was Visium Asset Management, an estimated $3.09M added.
- The largest BioDelivery Sciences International, Inc. seller in Q4 2013 was Fidelity Investments, an estimated $14.2M sold.
Based on aggregated 13F filings for Q4 2013.